Singapore

News

AI health tech Respiree closes $11.6m Series A

Health tech Respiree, developer of AI platforms to manage disease progression, has announced the successful closing of an $11.6m Series A financing.

News

Sanofi opens $595m manufacturing facility in Singapore

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products

News

AstraZeneca unveils plan for $1.5bn ADC plant in Singapore

AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to ma

News

AbbVie invests $223m in Singapore biologics site

AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs.

News

Novo Holdings co-leads $200m financing into Esco Lifescience...

Life sciences tools company Esco Lifesciences Group has scored $200m in a series A and crossover round co-led by Novo Holdings and

Views & Analysis

Regulatory timelines in the Asia-Pacific

Snapshot of clinical trial application processes in the region.

AI health tech Respiree closes $11.6m Series A

Sanofi opens $595m manufacturing facility in Singapore

AstraZeneca unveils plan for $1.5bn ADC plant in Singapore

AbbVie invests $223m in Singapore biologics site

Novo Holdings co-leads $200m financing into Esco Lifescience...

Regulatory timelines in the Asia-Pacific

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Singapore

Editor's Picks